Literature DB >> 14729294

The impact of the preventive medical message on intention to change behavior.

Stéphanie Frileux1, María Teresa Muñoz Sastre, Etienne Mullet, Paul Clay Sorum.   

Abstract

Clinicians counsel patients to adopt behaviors to reduce health risks. We studied, in the case of coronary artery disease, the impact of those parts of the preventive medical message clinicians can vary. We asked 150 French people (86 aged 20-30, 64 aged 60-80) to rate their intention to adopt a specific behavior-take medication, change their diet, or start exercising-in 64 scenarios, composed of two severities of disease manifestations (angina pectoris or heart attack); four levels of its probability of occurrence (5, 10, 15, or 20%) and the associated time horizon (20, 15, 10, or 5 years, respectively); and two levels of controllability of the risk (entirely under your control or not much you can do to reduce it). We found that all four parts of the message had significant main effects and did not interact with each other. Older participants had greater intention to adopt preventive behavior when the time horizon was short and younger ones when it was long. The only gender effect was that older women were more sensitive to time horizon. The message's parts were combined additively. Participants intended to change behavior even when told this would be of little use. We concluded that clinicians should, when possible, discuss all key parts of the preventive medical message; that they can, however, focus on one without reducing the others' impact; and that, at least for outcomes such as angina and heart attack, they should speak of risk with young patients using a long time horizon, with old patients using a short time horizon.

Entities:  

Mesh:

Year:  2004        PMID: 14729294     DOI: 10.1016/s0738-3991(03)00003-x

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  8 in total

1.  Adoption of cardiovascular risk reduction guidelines: a cluster-randomized trial.

Authors:  Kenneth A LaBresh; Adolfo J Ariza; Suzanne Lazorick; Robert D Furberg; Lauren Whetstone; Connie Hobbs; Janet de Jesus; Ilse G Salinas; Randall H Bender; Helen J Binns
Journal:  Pediatrics       Date:  2014-09       Impact factor: 7.124

Review 2.  Adding a life-course perspective to cardiovascular-risk communication.

Authors:  Kunal N Karmali; Donald M Lloyd-Jones
Journal:  Nat Rev Cardiol       Date:  2013-01-08       Impact factor: 32.419

3.  Expectation to improve cardiovascular risk factors control in participants to a health promotion program.

Authors:  Arnaud Chiolero; John Prior; Pascal Bovet; Jean-Christophe Masson; Roger Darioli
Journal:  J Gen Intern Med       Date:  2008-05       Impact factor: 5.128

Review 4.  What to say and how to say it: effective communication for cardiovascular disease prevention.

Authors:  Ann Marie Navar; Neil J Stone; Seth S Martin
Journal:  Curr Opin Cardiol       Date:  2016-09       Impact factor: 2.161

5.  The need for nursing instruction in patients receiving steroid pulse therapy for the treatment of autoimmune diseases and the effect of instruction on patient knowledge.

Authors:  Yu-Chu Pai
Journal:  BMC Musculoskelet Disord       Date:  2010-09-21       Impact factor: 2.362

6.  How information about the time requirements and legacy effects of treatments influence decision-making in patients with diabetes and hypertension.

Authors:  Neda Laiteerapong; Paige C Fairchild; Aviva G Nathan; Michael T Quinn; Elbert S Huang
Journal:  BMJ Open Diabetes Res Care       Date:  2016-04-27

Review 7.  Cardiovascular risk communication strategies in primary prevention. A systematic review with narrative synthesis.

Authors:  Stacey D Schulberg; Amy V Ferry; Kai Jin; Lucy Marshall; Lis Neubeck; Fiona E Strachan; Nicholas L Mills
Journal:  J Adv Nurs       Date:  2022-06-19       Impact factor: 3.057

8.  Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria.

Authors:  Thijs T W van Herpt; Symen Ligthart; Maarten J G Leening; Mandy van Hoek; Aloysius G Lieverse; M Arfan Ikram; Eric J G Sijbrands; Abbas Dehghan; Maryam Kavousi
Journal:  BMJ Open Diabetes Res Care       Date:  2020-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.